Literature DB >> 19213824

Efficacy of DynaCT digital angiography in the detection of the fistulous point of dural arteriovenous fistulas.

T Hiu1, N Kitagawa, M Morikawa, K Hayashi, N Horie, Y Morofuji, K Suyama, I Nagata.   

Abstract

BACKGROUND AND
PURPOSE: Identifying the precise hemodynamic features, including the fistulous point, is essential for treatments of dural arteriovenous fistulas (DAVFs). This study illustrates the efficacy of DynaCT digital angiograms obtained from a 3D C-arm CT to directly visualize the location of the fistulous points in DAVFs.
MATERIALS AND METHODS: This retrospective study observed 14 consecutive patients with DAVFs, which included 7 cavernous sinuses, 4 transverse-sigmoid sinuses, 2 convexity-superior sagittal sinuses, and 1 tentorial sinus. In the assessment of the practical applicability for the diagnosis of DAVFs, images obtained from 2D digital subtraction angiography (DSA) and DynaCT were comparatively evaluated.
RESULTS: In all patients, DynaCT digital angiography could clearly demonstrate the feeding arteries, the fistulous points, and the draining veins. Significant anatomic landmarks for the fistulous points with relationships to osseous structures were also provided. Compared with 2D DSA, DynaCT digital angiograms demonstrated 12 additional findings in 8 patients (57%), including the detection of the fistulous points (n = 7), the feeders (n = 1), the retrograde leptomeningeal drainage (n = 1), the draining veins (n = 1), and the venous anomaly (n = 2).
CONCLUSIONS: In comparison with 2D DSA, DynaCT may provide more detailed information to evaluate DAVFs. DynaCT digital angiograms have a high contrast and isotropic spatial resolution, allowing a reliable visualization of small vessels and fine osseous structures. Such detailed information, especially for the location of the fistulous points, could be very useful for either the endovascular or the surgical treatments of DAVFs.

Entities:  

Mesh:

Year:  2009        PMID: 19213824      PMCID: PMC7051467          DOI: 10.3174/ajnr.A1395

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  24 in total

1.  Recurrence of dural arteriovenous fistula in another location after selective transvenous coil embolization: report of two cases.

Authors:  Hiro Kiyosue; Shuichi Tanoue; Mika Okahara; Masanori Yamashita; Hirohumi Nagatomi; Hiromu Mori
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

2.  Combining endovascular and neurosurgical treatments of high-risk dural arteriovenous fistulas in the lateral sinus and the confluence of the sinuses.

Authors:  K Goto; P Sidipratomo; N Ogata; T Inoue; H Matsuno
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

3.  Clinical benefits of rotational 3D angiography in endovascular treatment of ruptured cerebral aneurysm.

Authors:  Toshi Abe; Masaru Hirohata; Norimitsu Tanaka; Yusuke Uchiyama; Kazuyuki Kojima; Kiminori Fujimoto; Alexander M Norbash; Naofumi Hayabuchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

Review 4.  Treatment of intracranial dural arteriovenous fistulas: current strategies based on location and hemodynamics, and alternative techniques of transcatheter embolization.

Authors:  Hiro Kiyosue; Yuzo Hori; Mika Okahara; Shuichi Tanoue; Yoshiko Sagara; Shunro Matsumoto; Hirofumi Nagatomi; Hiromu Mori
Journal:  Radiographics       Date:  2004 Nov-Dec       Impact factor: 5.333

5.  Intracranial dural arteriovenous fistulas: evaluation with combined 3D time-of-flight MR angiography and MR digital subtraction angiography.

Authors:  Kyo Noguchi; Elias R Melhem; Tadayoshi Kanazawa; Michiya Kubo; Naoya Kuwayama; Hikaru Seto
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

6.  Surgical treatment of intracranial dural arteriovenous fistulas.

Authors:  Satoshi Ushikoshi; Kiyohiro Houkin; Satoshi Kuroda; Takeshi Asano; Yoshinobu Iwasaki; Kazuo Miyasaka; Hiroshi Abe
Journal:  Surg Neurol       Date:  2002-04

7.  Three-dimensional rotational spinal angiography in the evaluation and treatment of vascular malformations.

Authors:  Charles J Prestigiacomo; Yasunari Niimi; Avi Setton; Alejandro Berenstein
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

8.  2D Thick-section MR digital subtraction angiography for the assessment of dural arteriovenous fistulas.

Authors:  N Horie; M Morikawa; N Kitigawa; K Tsutsumi; M Kaminogo; I Nagata
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

Review 9.  Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature.

Authors:  Robert A Willinsky; Steve M Taylor; Karel TerBrugge; Richard I Farb; George Tomlinson; Walter Montanera
Journal:  Radiology       Date:  2003-03-13       Impact factor: 11.105

10.  Classification and treatment of spontaneous carotid-cavernous sinus fistulas.

Authors:  D L Barrow; R H Spector; I F Braun; J A Landman; S C Tindall; G T Tindall
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

View more
  17 in total

1.  Turn-back embolization technique for effective transvenous embolization of dural arteriovenous fistulas.

Authors:  S Tanoue; H Kiyosue; Y Hori; T Abe; H Mori
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-05       Impact factor: 3.825

2.  CT angiography as a screening tool for dural arteriovenous fistula in patients with pulsatile tinnitus: feasibility and test characteristics.

Authors:  J Narvid; H M Do; N H Blevins; N J Fischbein
Journal:  AJNR Am J Neuroradiol       Date:  2011-03       Impact factor: 3.825

3.  Artery of the Superior Orbital Fissure: An Undescribed Branch from the Pterygopalatine Segment of the Maxillary Artery to the Orbital Apex Connecting with the Anteromedial Branch of the Inferolateral Trunk.

Authors:  H Kiyosue; S Tanoue; N Hongo; Y Sagara; H Mori
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-23       Impact factor: 3.825

4.  CT reconstruction and MRI fusion of 3D rotational angiography in the evaluation of pediatric cerebrovascular lesions.

Authors:  Prakash Muthusami; Nicholas Shkumat; Vanessa Rea; Albert H Chiu; Manohar Shroff
Journal:  Neuroradiology       Date:  2017-03-27       Impact factor: 2.804

5.  Fusion imaging using subtracted and unsubtracted rotational angiography for pretherapeutic evaluation of dural arteriovenous fistulas.

Authors:  Shuichi Tanoue; Hiro Kiyosue; Hiromu Mori; Norio Hongo; Mika Okahara; Takeshi Kubo
Journal:  Jpn J Radiol       Date:  2014-08-23       Impact factor: 2.374

6.  Simultaneous arteriovenous shunting and venous congestion identification in dural arteriovenous fistulas using susceptibility-weighted imaging: initial experience.

Authors:  L Letourneau-Guillon; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

7.  Use of Dyna CT in evaluation and treatment of pseudoaneurysm secondary to craniofacial tumor resection: Case report and diagnostic implications.

Authors:  Akil P Patel; Dheeraj Gandhi; Rodney J Taylor; Graeme Woodworth
Journal:  Surg Neurol Int       Date:  2014-04-11

8.  Computational Modeling of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension.

Authors:  M R Levitt; P M McGah; K Moon; F C Albuquerque; C G McDougall; M Y S Kalani; L J Kim; A Aliseda
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

9.  Automated double-cone-beam CT fusion technique. Enhanced evaluation of glue distribution in cases of spinal dural arteriovenous fistula (SDAVF) embolisation.

Authors:  Giuseppe Faragò; V Caldiera; C Antozzi; A Bellino; A Innocenti; E Ciceri
Journal:  Eur Radiol       Date:  2016-08-26       Impact factor: 5.315

10.  3D C-arm conebeam CT angiography as an adjunct in the precise anatomic characterization of spinal dural arteriovenous fistulas.

Authors:  T D Aadland; K R Thielen; T J Kaufmann; J M Morris; G Lanzino; D F Kallmes; B A Schueler; H Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.